NextGen Jane (Jane) is a diagnostic startup focused on developing tests based off a patented tampon collection technology. Jane's technology platform allows users to collect menstrual and cervicovaginal samples with an everyday household product, preserve nucleic acids and other analytes important for disease detection and ship them off to a lab for in-depth sequencing analysis and disease detection. The NextGen Jane system allows for superior preservation of DNA and RNA of cells from the endometrium, cervix, fallopian tubes and ovaries. Jane's mission is to transform biological signals to digital diagnoses to empower the individual with early detection of disease, and move the locus of power and health management from the clinic to the consumer.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
04/02/19	$9,000,000	Series A	Access Industries Angela MacFarlane Anne Morriss David Walt Deborah Kilpatrick Frances Frei George Whitesides Kacey Fitzpatrick Liminal Ventures Material Impact Rox Anderson Viking Global Investors	undisclosed